49. 全身性エリテマトーデス Systemic lupus erythematosus Clinical trials / Disease details
臨床試験数 : 993 / 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00004643 (ClinicalTrials.gov) | February 1995 | 24/2/2000 | Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus Erythematosus | Lupus Erythematosus, Systemic | Drug: cytarabine | National Center for Research Resources (NCRR) | University of Michigan | Completed | 18 Years | 64 Years | Both | 10 | Phase 2 | NULL |